tiprankstipranks

Roivant Sciences, Ltd. Insider Profile

4 Followers
Roivant Sciences, Ltd., Ten Percent Owner at Arbutus Biopharma, holds 38.85M shares in Arbutus Biopharma (Ticker: ABUS).
tipranks
Roivant Sciences, Ltd.

Roivant Sciences, Ltd.
Arbutus Biopharma (ABUS)
Ten Percent Owner

Ranked #58,879 out of 83,232 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-25.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$161M
100.00%
A breakdown of Roivant Sciences, Ltd.'s holdings

Insider Roles

Arbutus Biopharma
(ABUS)
Ten Percent Owner
Roles that Roivant Sciences, Ltd. holds in companies

Most Profitable Insider Trade

Stock:
Arbutus Biopharma
(ABUS)
Rating:Informative Buy
Date:Jan 16, 2018 - Jan 16, 2019
Return:-22.90%
The most profitable trade made by Roivant Sciences, Ltd.

Roivant Sciences, Ltd.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Arbutus Biopharma
Oct 20, 2021
Ten Percent Owner
Uninformative Buy
$161.22M
Success Rate for
ABUS
0 out of 2 profitable transactions on
ABUS
0%
Average Return for
ABUS
Average return per transaction on
ABUS
-25.25%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 20, 2021
Uninformative Buy
$0.00
-
Oct 23, 2017
Informative Buy
$50.00M
-
$100.00
-27.60%
Jan 16, 2018
Informative Buy
$66.40M
-
$100.00
-22.90%
List of latest transactions for each holding click on a transaction to see Roivant Sciences, Ltd.'s performance on stock

Roivant Sciences, Ltd. insider profile FAQ

What is the percentage of profitable transactions made by Roivant Sciences, Ltd.?
The percentage of profitable transactions made by Roivant Sciences, Ltd. is 0%.
    What is the average return per transaction made by Roivant Sciences, Ltd.?
    The average return per transaction made by Roivant Sciences, Ltd. is -25.20%.
      What stocks does Roivant Sciences, Ltd. hold?
      Roivant Sciences, Ltd. holds: ABUS stocks.
        What was Roivant Sciences, Ltd.’s latest transaction?
        Roivant Sciences, Ltd. latest transaction was an Uninformative Buy of ―.
          What was Roivant Sciences, Ltd.'s most profitable transaction?
          Roivant Sciences, Ltd.’s most profitable transaction was an Informative Buy of ABUS stock on January 16, 2018. The return on the trade was -22.90%.
            What is Roivant Sciences, Ltd.'s role in Arbutus Biopharma?
            Roivant Sciences, Ltd.'s role in Arbutus Biopharma is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.